FDA Postmarket Guidance Hammers Home Positions On Foreign Trials, Real-World Evidence

 
• By Sarah Karlin-Smith
  
diverse group of people
FDA issued draft guidance on obtaining data on unrepresented populations postmarket • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Post-Marketing Regulation & Studies

More from Product Reviews